Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001971 · ClinicalTrials.gov registry record
Evaluation of Patients With Liver Disease
A clinical trial of Hepatitis C and Hepatitis B, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Recruiting
- Registry status
- 8,050
- Enrollment target
- 1
- Study location
NCT00001971 is a study of Hepatitis C and Hepatitis B that is actively recruiting participants, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 8,050 participants, above the 1,814-participant average among 106 other Hepatitis C trials with a reported enrollment target (344% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001971, a study of Hepatitis C and Hepatitis B, is actively recruiting participants, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- RECRUITING
- Registry status
- 8,050 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked to provide blood and urine samples for laboratory testing and will undergo an ultrasound of the liver. Ultrasound examinations use sound waves to determine the size and texture of the liver. After the initial visit subjects will be requested to follow-up once a year at the outpatient department for a similar check-up. Additional tests may be requested throughout the study to provide information for other research studies and individual consent will be requested. These tests may include liver biopsies, skin biopsies, and / or specialized blood, plasma, and lymphocyte examinations. Subjects that qualify for medications presently being studied may be offered the opportunity to benefit from experimental therapy.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,050 participants |
| Start Date | 1992-05-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001971
The ClinicalTrials.gov registry entry for NCT00001971 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,814-participant average among 106 other Hepatitis C trials with a reported enrollment target (344% higher). The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT00001971 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001971 about?
NCT00001971 is a clinical study titled "Evaluation of Patients With Liver Disease". The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting the liver. Patients participating in the study will first undergo a routine check-up as an outpatient. They will be asked...
What is the current status of trial NCT00001971?
This trial is currently recruiting. The enrollment target is 8,050 participants. The study started on 1992-05-27.
What conditions does trial NCT00001971 study?
This clinical trial studies the following conditions: Hepatitis C, Hepatitis B, Liver Disease, Hepatitis D.
Who is sponsoring clinical trial NCT00001971?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001971 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
-
HCV Tappt Adherence Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.